| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |